Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2021 | Story Nonsindiso Qwabe | Photo Supplied
A story of hope, courage, resilience, and working your way to the top. Dilahlwane Mohono started working as a cleaner at the UFS in 1992. Today, she is a Senior Faculty Officer in the Faculty of Natural and Agricultural Sciences and holds two honours degrees.

Fuelled by her deep pain due to falling pregnant during her matric year, as well as the desire to one day hold a qualification, Dilahlwane Mohono – Senior Faculty Officer in the Faculty of Natural and Agricultural Sciences – says her story is her favourite, as it is a story of hope, courage, resilience, and working your way to the top.

Because of her pregnancy, Mohono did not complete Grade 12 in 1990. She got married immediately thereafter. In 1992, she began working as a cleaner for a company that was insourced to provide meals on the University of the Free State Qwaqwa Campus. She says this experience often left her with mixed feelings, as it hurt to see her peers studying further, but this is also what ultimately motivated her to complete her matric. “Graduation ceremonies were the most painful events for me. This eventually pushed me to turn to ABET to complete my matric in 1994. From there, I was determined to start my academic journey, so I registered with Stanford Business College for a Secretariat and Computer Skills Diploma. It was a six-month course, but I graduated in the end. That graduation inspired me. It motivated me to study further. Juggling work and studying became challenging, because I was a young mother and wife, but I had to attend classes after work.”

The joy of education

In 2000, she registered for a Higher Diploma with Unisa, and at the same time took up a new position in the library on campus. At the time, it was still called the University of the North Qwaqwa Campus. She recalls this as the beginning of her upward trajectory in life. “The joy of education and seeing how far I have come made me realise how much potential I have, so in 2003 I registered for a BA Sociology and English degree at the UFS, and thereafter went on to do my BA Honours in Sociology.”

She took up a new position as Assistant Officer in the Faculty of Education. Wishing to be relevant to her new faculty, Mohono completed a Postgraduate Certificate in Education (PGCE), and thereafter a second honours degree in Curriculum Studies. “I felt like I was flowing. My colleagues helped me out and I wanted to ensure that I was the best in everything, because I did not want to disappoint them. What always encouraged me, were my children. I separated from my husband in 2003, so I found myself raising my kids single-handedly, and I needed to show them that we could all make it, and life would still go on.”

In 2018, the Faculty of Natural and Agricultural Sciences advertised a senior position. Mohono says she took a chance and applied because she wanted more growth. “I am now a Senior Faculty Officer. I was privileged to be afforded an opportunity to work for the university, so I always thought – how can I work in an academic higher learning environment and not use the opportunity to study and pursue an education.”

Is there a woman who inspires you and who you would like to celebrate this Women’s Month, and why?
It has to be my late mother. She was a very hardworking woman, but she passed on very early, in her early 40s. She worked in the same dining hall I started in, and a lot of the women I worked with then worked with her too. They took me under their wings and motivated me to continue chasing my dreams. Some were not even educated themselves, but they motivated me. I drew a lot of inspiration from them.

What advice would you give to the 15-year-old you?

She must take pride in being a woman, know who she is, and know that she must be brave and confident, and run with education as the key to her success. If it wasn’t for education, I shudder to think where I could’ve been. When I look back and see what I have achieved, being able to rise from all that while single-handedly raising my children, it makes me feel very strongly about myself. I am a very powerful woman. 

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept